JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2006; 48:2315-2323, doi:10.1016/j.jacc.2006.07.060 (Published online 9 November 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.07.060v1
48/11/2315    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zymek, P.
Right arrow Articles by Frangogiannis, N. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zymek, P.
Right arrow Articles by Frangogiannis, N. G.

PRECLINICAL STUDY

The Role of Platelet-Derived Growth Factor Signaling in Healing Myocardial Infarcts

Pawel Zymek, MD*, Marcin Bujak, MD*, Khaled Chatila, MD*, Anna Cieslak, MS*, Geeta Thakker, PhD{dagger}, Mark L. Entman, MD, FACC* and Nikolaos G. Frangogiannis, MD, FACC*,*

* Section of Cardiovascular Sciences, the DeBakey Heart Center, Baylor College of Medicine, and the Methodist Hospital, Houston, Texas
{dagger} Section of Atherosclerosis, the DeBakey Heart Center, Baylor College of Medicine, and the Methodist Hospital, Houston, Texas.

Manuscript received June 1, 2006; revised manuscript received July 13, 2006, accepted July 17, 2006.

* Reprint requests and correspondence: Dr. Nikolaos G. Frangogiannis, Section of Cardiovascular Sciences, One Baylor Plaza, M/S F-602, Baylor College of Medicine, Houston, Texas 77030. (Email: ngf{at}bcm.tmc.edu).

OBJECTIVES: This study sought to examine the role of platelet-derived growth factor (PDGF) signaling in healing myocardial infarcts.

BACKGROUND: Platelet-derived growth factor isoforms exert potent fibrogenic effects through interactions with PDGF receptor (PDGFR)-{alpha} and PDGFR-ß. In addition, PDGFR-ß signaling mediates coating of developing vessels with mural cells, leading to the formation of a mature vasculature. We hypothesized that PDGFR activation may regulate fibrosis and vascular maturation in healing myocardial infarcts.

METHODS: Mice undergoing reperfused infarction protocols were injected daily with a neutralizing anti–PDGFR-ß antibody (APB5), an anti-PDGFR-{alpha} antibody (APA5), or control immunoglobulin G, and were killed after 7 days of reperfusion.

RESULTS: The PDGF-B, PDGFR-{alpha}, and PDGFR-ß mRNA expression was induced in reperfused mouse infarcts. Perivascular cells expressing phosphorylated PDGFR-ß were identified in the infarct after 7 days of reperfusion, indicating activation of the PDGF-BB/PDGFR-ß pathway. The PDGFR-ß blockade resulted in impaired maturation of the infarct vasculature, enhanced capillary density, and formation of dilated uncoated vessels. Defective vascular maturation in antibody-treated mice was associated with increased and prolonged extravasation of red blood cells and monocyte/macrophages, suggesting increased permeability. These defects resulted in decreased collagen content in the healing infarct. In contrast, PDGFR-{alpha} inhibition did not affect vascular maturation, but significantly decreased collagen deposition in the infarct.

CONCLUSIONS: Platelet-derived growth factor signaling critically regulates postinfarction repair. Both PDGFR-ß– and PDGFR-{alpha}–mediated pathways promote collagen deposition in the infarct. Activation of PDGF-B/PDGFR-ß is also involved in recruitment of mural cells by neovessels, regulating maturation of the infarct vasculature. Acquisition of a mural coat and maturation of the vasculature promotes resolution of inflammation and stabilization of the scar.

Abbreviations and Acronyms
  APA = anti–PDGFR-{alpha} antibody
  APB = anti–PDGFR-ß antibody
  IgG = immunoglobulin G
  PCR = polymerase chain reaction
  PDGF = platelet-derived growth factor
  PDGFR = platelet-derived growth factor receptor
  SMA = smooth muscle actin




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J.-X. Chen and A. Stinnett
Disruption of Ang-1/Tie-2 Signaling Contributes to the Impaired Myocardial Vascular Maturation and Angiogenesis in Type II Diabetic Mice
Arterioscler. Thromb. Vasc. Biol., September 1, 2008; 28(9): 1606 - 1613.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Bujak, M. Dobaczewski, K. Chatila, L. H. Mendoza, N. Li, A. Reddy, and N. G. Frangogiannis
Interleukin-1 Receptor Type I Signaling Critically Regulates Infarct Healing and Cardiac Remodeling
Am. J. Pathol., July 1, 2008; 173(1): 57 - 67.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. Andrae, R. Gallini, and C. Betsholtz
Role of platelet-derived growth factors in physiology and medicine
Genes & Dev., May 15, 2008; 22(10): 1276 - 1312.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Bujak, H. J. Kweon, K. Chatila, N. Li, G. Taffet, and N. G. Frangogiannis
Aging-Related Defects Are Associated With Adverse Cardiac Remodeling in a Mouse Model of Reperfused Myocardial Infarction
J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1384 - 1392.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.